Tafenoquine Is a Promising Drug Candidate for the Treatment of Babesiosis
Mingming Liu, Shengwei Ji, Daisuke Kondoh, Eloiza May Galon, Jixu Li, Mizuki Tomihari, Masashi Yanagawa, Michihito Tagawa, Mami Adachi, Masahito Asada, Ikuo Igarashi, Aiko Iguchi, Xuenan Xuan
Abstract
Due to drug resistance, commonly used anti- Babesia drugs have limited efficacy against babesiosis and inflict severe side effects. Tafenoquine (TAF) was approved by the U.S.
Topics & Concepts
BabesiosisDrugMedicineIntensive care medicineDrug candidatePharmacologyVirologyVector-borne infectious diseasesInsect and Pesticide ResearchMosquito-borne diseases and control